Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 220Head and Neck Neoplasms 172Carcinoma, Non-Small-Cell Lung 104Melanoma 63Neoplasms 56Colorectal Neoplasms 55Uterine Cervical Neoplasms 53Ovarian Neoplasms 50Stomach Neoplasms 48Neoplasm Metastasis 46Breast Neoplasms 46Triple Negative Breast Neoplasms 45Lung Neoplasms 44Carcinoma, Renal Cell 40Esophageal Neoplasms 37Nasopharyngeal Carcinoma 33Endometrial Neoplasms 33Pancreatic Neoplasms 32Thyroid Neoplasms 30Prostatic Neoplasms 26Carcinoma, Squamous Cell 26Sarcoma 25Colonic Neoplasms 24Urinary Bladder Neoplasms 23Small Cell Lung Carcinoma 23Oropharyngeal Neoplasms 23Carcinoma, Transitional Cell 23Carcinoma 22Salivary Gland Neoplasms 20Nasopharyngeal Neoplasms 20

Interventions

toripalimab 1rocakinogene sifuplasmid 1VGX-3100 1MEDI0457 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Head and Neck Squamous Cell Cancer × Head & Neck × Clear all
NCT04856631 2022-12-19

A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 1/2 Unknown
88 enrolled
Head & Neck

Head and Neck Squamous Cell Cancer

NCT02163057 2021-01-22

Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 1/2 Completed
22 enrolled 14 charts
Head & Neck

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡